Introduction of new technology: the surgical point of view.
Introduction of new non-pharmacological technology is challenging and the methodology for evaluating such technologies is much less standardized than when dealing with new pharmacological substances. It is, however, as important to use randomized design with blinded assessment and combine that with prospective population based registries to be able to analyze generalizability.
Bergqvist
D
D
Section of Vascular Surgery, Department of Surgery, University Hospital, Uppsala SE-751 85, Sweden. david.bergqvist@surgsci.uu.se
D020811:Biomedical Technology / Q000592:standards; D004059:Diffusion of Innovation; D013502:General Surgery; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012042:Registries